Skip to content

Medical emergency? What to do

Drug Slows Severe Alzheimer's Symptoms for One Year

3-RXPublished January 10, 20063 min read

Key points

  • A drug used to treat symptoms of moderate to severe Alzheimer's disease appears to be effective for one year, according to the results of a new multicenter study that provides additional support for the continuing effectiveness of the treatment, called Namenda®, for patients in the later stages of the disease.
  • Namenda® was approved in October 2003 by the Food and Drug Administration for the treatment of moderate to severe Alzheimer's disease.
  • All patients were evaluated with a wide range of tests to assess cognitive and functional abilities, and behavior.
  • Namenda® is the only approved treatment for slowing the later stages of the disease, when patients are in the most distress.

A drug used to treat symptoms of moderate to severe Alzheimer's disease appears to be effective for one year, according to the results of a new multicenter study that provides additional support for the continuing effectiveness of the treatment, called Namenda®, for patients in the later stages of the disease.

"This study demonstrates that it is possible to alleviate some of the cognitive and functional losses associated with the later stages of Alzheimer's, providing a basis for greater optimism on the part of caregivers," says Barry Reisberg, M.D., Professor of Psychiatry at NYU School of Medicine, the lead investigator of the study, which is published in the January 2006 issue of the Archives of Neurology.

"Our study verifies that this medication continues to be beneficial and is safe with remarkably few side effects," said Dr. Reisberg, who is also Clinical Director of the Silberstein Aging and Dementia Research Center at NYU School of Medicine.

Namenda® was approved in October 2003 by the Food and Drug Administration for the treatment of moderate to severe Alzheimer's disease. The approval was based partly on a rigorous 28-week study of 252 people who were randomly chosen to receive the drug or a placebo. The results, published in the prestigious New England Journal of Medicine in the spring of 2003, showed that the drug could slow the downward spiral of the disease. Dr. Reisberg also was the principal investigator of this study.

The new study evaluated the effects of the medication in the same patients for an additional 24 weeks in what is called an "open label extension." All patients who received a placebo previously were given the drug. The study enrolled 175 patients, 80 of whom had received the placebo. The remaining patients continued to receive the drug. The study was paid for by the German company Merz Pharmaceutical GmbH, which markets the medicine in Germany and elsewhere. Forest Pharmaceuticals Inc sells Namenda® in the United States.

All patients were evaluated with a wide range of tests to assess cognitive and functional abilities, and behavior. Those who were switched from the placebo to Namenda® showed a significantly slower rate of decline in a test of their ability to perform daily activities and in a test designed to measure their cognition, compared with the rate of decline previously. They also showed a significant benefit on a test designed to evaluate overall abilities and behavior that includes input from caregivers.

In the patients who continued to receive Namenda®, the benefits of the treatment appeared to be maintained, according to the study.

Namenda® is the only approved treatment for slowing the later stages of the disease, when patients are in the most distress. In the moderate to severe stages, patients begin to lose the ability to care for themselves. They generally have trouble dressing and bathing; many can no longer make a cup or coffee or tea for themselves.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underNeurology

Keep reading

Brain

Research Explores Little-Understood Brain Disease

The population of aged persons worldwide is expanding rapidly, and it is becoming increasingly clear that there are many different diseases that affect the minds of these individuals. Researchers at the University of…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.